RSCM
KYNB

Rock Springs Capital Management’s Kyntra Bio KYNB Stock Holding History

Rock Springs Capital Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12,507
Closed -$8.33M – 160
2021
Q2 		$8.33M Hold
12,507
– – 0.16% 124
2021
Q1 		$10.9M Buy
12,507
+132
+1% +$141K 0.24% 106
2020
Q4 		$11.5M Buy
12,375
+4
+0% +$4.21K 0.24% 107
2020
Q3 		$12.7M Sell
12,371
-247
-2% -$266K 0.32% 86
2020
Q2 		$12.8M Buy
12,618
+378
+3% +$351K 0.35% 92
2020
Q1 		$10.6M Hold
12,240
– – 0.44% 73
2019
Q4 		$13.1M Hold
12,240
– – 0.41% 78
2019
Q3 		$11.3M Hold
12,240
– – 0.45% 70
2019
Q2 		$13.8M Hold
12,240
– – 0.5% 68
2019
Q1 		$16.6M Hold
12,240
– – 0.64% 54
2018
Q4 		$14.2M Hold
12,240
– – 0.67% 47
2018
Q3 		$18.6M Sell
12,240
-40
-0.3% -$61.6K 0.67% 49
2018
Q2 		$19.2M Sell
12,280
-100
-0.8% -$130K 0.74% 45
2018
Q1 		$14.3M Sell
12,380
-620
-5% -$816K 0.61% 63
2017
Q4 		$15.4M Hold
13,000
– – 0.7% 52
2017
Q3 		$17.5M Buy
13,000
+1,800
+16% +$1.9M 0.81% 47
2017
Q2 		$9.04M Buy
11,200
+1,600
+17% +$1.11M 0.46% 65
2017
Q1 		$5.92M Hold
9,600
– – 0.34% 82
2016
Q4 		$5.14M Buy
9,600
+260
+3% +$130K 0.34% 77
2016
Q3 		$4.83M Buy
9,340
+340
+4% +$160K 0.3% 88
2016
Q2 		$3.69M Buy
9,000
+840
+10% +$385K 0.27% 96
2016
Q1 		$4.34M Buy
8,160
+560
+7% +$279K 0.36% 86
2015
Q4 		$5.79M Hold
7,600
– – 0.44% 77
2015
Q3 		$4.17M Hold
7,600
– – 0.34% 91
2015
Q2 		$4.46M Buy
7,600
+1,548
+26% +$900K 0.33% 95
2015
Q1 		$4.75M Hold
6,052
– – 0.44% 73
2014
Q4 		$4.14M Buy
+6,052
New +$3.89M 0.48% 63

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rock Springs Capital Management's KYNB Position: Q3 2021 in Review

Rock Springs Capital Management sold out of Kyntra Bio (KYNB) in Q3 2021, closing a stake of 12,507 shares — an estimated $8.33M sold.

Rock Springs Capital Management first reported a position in KYNB in Q4 2014 and held it in 27 quarters. The position peaked at $19.2M in Q2 2018. 164 funds tracked by Wall St. Rank hold KYNB as of Q3 2021.

  • Rock Springs Capital Management reported no remaining Kyntra Bio position as of Q3 2021 after selling out during the quarter.
  • Rock Springs Capital Management sold 12,507 Kyntra Bio shares in Q3 2021, an estimated $8.33M.
  • Rock Springs Capital Management first reported a position in Kyntra Bio in Q4 2014 and held it in 27 quarters.
  • Rock Springs Capital Management's Kyntra Bio position peaked at $19.2M in Q2 2018.
  • 164 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2021.

Based on Rock Springs Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.